Mannkind (MNKD) Change in Accured Expenses (2010 - 2026)

Mannkind's (MNKD) quarterly Change in Accured Expenses came in at -$5.8 million in Q1 2026, down 4406.72% year-on-year from $134000.0 in Q1 2025, and down 143.23% on a QoQ basis from $13.4 million in Q4 2025.

Mannkind (MNKD) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 17 years of Change in Accured Expenses data on file, last reported at -$5.8 million in Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 4406.72% year-over-year to -$5.8 million in Q1 2026; TTM through Mar 2026 was -$2.6 million, a 18.22% increase from a year earlier, with the FY2025 full-year figure at $3.3 million, up 220.46% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$5.8 million, down from $13.4 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for MNKD reached as high as $13.4 million in Q4 2025 and fell as low as -$9.5 million in Q2 2025.
  • Historically, Change in Accured Expenses has averaged $39117.6 across 5 years, with a median of -$644000.0 in 2022.
  • Across the five-year window, Change in Accured Expenses surged 769.45% in 2023 and tumbled 4406.72% in 2026, its largest moves.
  • Year by year, Change in Accured Expenses stood at -$1.6 million in 2022, then jumped by 769.45% to $10.4 million in 2023, then slumped by 79.81% to $2.1 million in 2024, then surged by 533.9% to $13.4 million in 2025, then sank by 143.23% to -$5.8 million in 2026.
  • Per Business Quant data, the three most recent Change in Accured Expenses figures were -$5.8 million in Q1 2026, $13.4 million in Q4 2025, and -$761000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 67,011.97 Bn 67,011.68 Bn - 1.13 Mn
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - 931,000.00
4 BeOne Medicines 471.88 Bn 467.08 Bn 1.35 Bn -16.82 Mn
5 Vertex Pharmaceuticals 122.20 Bn 114.96 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 69.93 Bn 61.17 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.85 Bn 50.67 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn -176.03 Mn
10 Mannkind 1.25 Bn 1.12 Bn 82.66 Mn -5.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.77 Mn
Mar 31, 2026 -5.77 Mn
Dec 31, 2025 13.35 Mn
Dec 31, 2025 13.35 Mn
Sep 30, 2025 -761,000.00
Sep 30, 2025 -761,000.00
Jun 30, 2025 -9.47 Mn
Jun 30, 2025 -9.47 Mn
Mar 31, 2025 134,000.00
Mar 31, 2025 134,000.00
Dec 31, 2024 2.11 Mn
Dec 31, 2024 2.11 Mn
Sep 30, 2024 -3.05 Mn
Sep 30, 2024 -3.05 Mn
Jun 30, 2024 -2.43 Mn
Jun 30, 2024 -2.43 Mn
Mar 31, 2024 670,000.00
Mar 31, 2024 670,000.00
Dec 31, 2023 10.43 Mn
Dec 31, 2023 10.43 Mn